Under construction – not a live service
Sign in

2022-503119-40-00Not yet recruitingPhase 3

Clinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-groups, randomised controlled trial

Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Next steps

Brief summary (registry, in English)

The main aims of the present study are: i. to assess the efficacy of ixekizumab monotherapy versus methotrexate monotherapy in PsA dactylitis; ii. to evaluate the degree of response by using the DACTOS score

Status (registry)
Not yet recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
First submitted
23 Dec 2024
Start date
1 Dec 2025
Lead sponsor
Azienda Ospedaliera Ordine Mauriziano Di Torino
EU CT number
2022-503119-40-00

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 60
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Lab values

  • -participation in another concurrent clinical intervention study within 30 days of randomization; - planned administration of live vaccines during the study period; - previous treatment with lymphocyte-depleting therapies or alkylating agents; - presence of one or more contraindication reported in datasheets of administered study drugs; - haemoglobin<9.0 g/dL, white-cell count<3.0×109/L, absolute neutrophil count<1.2×109/L, platelet count<100×109/L; - estimated glomerular filtration rate<40 ml/min (method of Cockcroft and Gault); - aspartate aminotransferase and/or alanine aminotransferase >1.5 times the upper normal range; - another autoimmune rheumatic disease except Sjogren’s syndrome; - recent, current, or chronic infection, including hepatitis B or hepatitis C infection or human immunodeficiency virus infection; - evidence of active, latent, or inadequately-treated Mycobacterium Tuberculosis infection; - a history of lymphoproliferative disorder; - major surgery within two weeks before starting study drugs, or having unhealed operation wounds; - history of cancer, except adequately treated, non-metastatic basal-cell or squamous-cell cancer of the skin or cervical carcinoma in situ; - Pregnant or lactating women (women of childbearing potential should have a negative test for HCG); - significant history of alcohol/drug abuse or addiction; - foreseeable inability to cooperate with given instructions and study procedures; - any condition precluding the administration of study drugs in compliance with datasheets indications; - any condition or laboratory parameter precluding the inclusion of the participant according to investigator.

Who the study is looking for

  • adult age (≥ 18 years); - fulfilment of CASPAR criteria for PsA [2]; - naïve to csDMARDs and/or bDMARDs;; - presence of active dactylitis, diagnosed and evaluated at each centre through physical examination

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (9)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universita Politecnica Delle MarcheAnconaItalyNot yet recruiting
Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini CtoMilanItalyNot yet recruiting
Universita Degli Studi Di PadovaPadovaItalyNot yet recruiting
Universita' Degli Studi Di PalermoPalermoItalyNot yet recruiting
Istituti Clinici Scientifici Maugeri S.p.A. Societa' Benefit In Forma Abbreviata Istituti Clinici Scientifici Maugeri S.p.A. Sb O Anche Ics Maugeri S.p.A. Sb O Maugeri S.p.A. SbPaviaItalyNot yet recruiting
Università degli Studi di PerugiaPerugiaItalyNot yet recruiting
Policlinico Universitario Campus Bio-MedicoRomaItalyNot yet recruiting
Azienda Sanitaria Locale Roma 1RomeItalyNot yet recruiting
Azienda Ospedaliera Ordine Mauriziano di TorinoTurinItalyNot yet recruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.